Abstract
This chapter reviews the results of molecular modeling of iodine-containing drugs. They are active ingredients of mixtures that in aqueous solutions consist of molecular iodine, bio-organic ligands, and potassium and lithium halogenides. In these drugs molecular iodine is in such an active form that after oral administration it minimizes toxic effects in humans. Previously it was shown that the active complex (AC) of the drugs contains molecular iodine that is located inside α-helix of dextrin and is coordinated by lithium halides and polypeptides (LiI5-α-dextrin polypeptide). In these types of complexes the electronic structure of the I2 molecule is different from the electronic structure of I2 in complexes with organic ligands, or in its free state. Interestingly, in the AC the molecular iodine exhibits acceptor properties with respect to polypeptides, and donor properties with respect to lithium halide. Our group was the first to propose the molecular model of active complexes of the iodine-containing drugs. This was based on the results of calculations performed using the DFT-B3PW91/midi approach. Model system of the water-glycine KI3-LiCl-ethanol was considered in this study. The calculations of the spectral parameters of the proposed structures are in good agreement with the experimental data of UV and IR spectral investigations. We have shown that α-dextrins ensure the presence in the studied mixtures of the three active centers located within the α-dextrin helix: molecular iodine coordinated lithium halogenides and polypeptides, triiodide, and lithium halogenides. Using UV spectroscopy, the interaction of α-dextrin-LiCl(I)-I2-polypeptid with the AGA nucleotide triplet was investigated. Comparison of the quantum chemical calculations carried out for electronic transitions obtained for the structure that models the interaction of α-dextrin-LiCl(I)-I2-polypeptid with the nucleotide triplet indicates that the DNA nucleotides can displace polypeptide and form stable complexes with molecular iodine and lithium halogenides. In such structures, molecular iodine binds both the nucleotide triplet and lithium halogenides. We have shown that the presence of molecular iodine is vital for activity of compounds that inhibit the active site of HIV-1 integrase. Iodine prevents the active site of integrase from the formation of a complex with HIV DNA and inhibits the active complex of integrase and viral DNA, becoming the center of another nucleoprotein complex, and binding together the active site of integrase and viral DNA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Svensson PH, Kloo L (2003) Chem Rev 103:1649
Zhang FS, Lynden-Bell RM (2005) Eur Phys J D 34:129
Jena NK, Josefsson I, Eriksson SK, Hagfeldt A, Siegbahn H, Bjorneholm O, Rensmo H, Odelius M (2015) Chem Eur J 21:4049
Shilov GV, Kasheva ON, Deshenko OA, Chernovenc MS, Simonen CC, Goleva VE, Pishev AI (2002) Russ J Phys Chem 76:1295
Grozema FC, Zijstra RJ, Swart M, Duijnen PT (1999) Int J Quantum Chem 75:709
Su JT, Zewail AH (1998) J Phys Chem A 102:4082
Engel PS, Duan S, Whitmire KH (1998) J Org Chem 63:5666
Esseffar M, Bouah W, Lamsabbi A, Abboud JM, Notario R, Yanez M (2000) J Am Chem Soc 122:2300
Daga V, Hadjikakou SK, Hadjliadis N, Kubieki M, Santos JHZ, Butler IS (2002) Eur J Inorg Chem 7:1718
Antoniadis CD, Hadjikakou SK, Hadjiliadies N, Kubieki M, Butler IS (2004) Eur J Inorg Chem 21:4324
Moulay S (2013) J Polym Eng 33(5):389
Nessreen A, Al-Hashimi, Hussein YHA (2010) Spectrochim Acta Part A 75:198
Khouba Z, Benabdallah T, Maschke U (2014) Spectrochim Acta Part A Mol Biomol Spectrosc 125:61
Karlsen EM, Spanget-Larsen J (2009) Chem Phys Lett 473:227
Karuma T, Neelima K, Venkateshwarlu G, Swamy PY (2006) J Sci Ind 65:808
Lagoce JF, Jambut-Absil AC, Buxeraud J, Moesch C, Raby C (1990) Chem Pharm Bull 38(8):2172
International Application (2000) Ilyin Alexandr, Gab-rielyan Emil, Mkhitaryan, Levon Antiviral and antibacte-rial pharmaceutical preparation “Armenicum” And its use for treatment of infectious diseases. Patent No.: PCT/AM 2000/000002
Mkhitaryan LM, Davtyan TK, Gabrielyan ES, Gevorkyan LA (2007) Int J Biotechnol 9(3,4):301
Ilin AI, Kulmanov ME (2004) Bactericide and viricidal pharmaceutical preparation for prophylaxis and treatment mono and mixtinfections, manner of prophy-laxis o/or treatment viral, bacterium and mixtinfection. Patent No.: 15116
Yuldasheva GA, Zhidomirov GM, Ilin AI (2012) Biotechnol Appl Biochem 59(1):29
Yuldasheva GA, Zhidomirov GM, Leszczynski J, Ilin AI (2013) J Mol Struct 1033:321
Nagaoka M, Okuyama-Yoshida N (1998) J Phys Chem A 102(42):8202
Grasjo J, Andersson E, Forsberg J, Duda L, Henke E, Pokapanich W, Bjrneholm O, Andersson J, Pietzsch A, Hennies F, Rubensson JE (2009) J Phys Chem B 113(49):16002
Hwang TK, Eom G-Y, Choi M-S, Jang S-W, Kim J-Y, Lee S (2011) J Phys Chem B 115(33):10147
Aikens CH, Gordon MS (2006) J Am Chem Soc 128(39):12835
Rahaman O, van Duin ACT, Goddard WA, Doren DJ (2011) J Phys Chem B 115(2):249
Tajkhorshid E, Jalkanen KJ, Suhai S (1998) J Phys Chem B 102(30):5899
Minkov VS, Chesalov UA, Boldyreva EV (2010) J Struct Chem 51(6):1091
Thoma JA, French D (1960) J Am Chem Soc 82:4144
Klamt A, Schuurmann, GJ (1993) Chem Soc Perkin Trans 2:799
Shart SB, Gellene GI (1997) J Phys Chem A 101:2192
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian 09, Revision C.01. Gaussian Inc., Wallingford
Parsons CL, Corliss HP (1910) J Am Chem Soc. 32(11):1367
Immel S, Lichtenthaler FW (2000) Starch 52(1):1
Refat MS, Killa HMA, Hamada MA, El-Sayed MY (2011) Bull Chem Soc Ethiop 25(1):137
Refat MS, Killa HMA, El-Maghraby A, El-Sayed MY (2012) Bul Chem Commun 44(1):74
Burgess AE, Davidson JC (2012) J Chem Educ 89:814–816
Calabrese VT, Arshad Khan A (2000) J Phys Chem A 104:1287
Gerasimova GV, Variamova TM, Mushtakova SP (2008) Russ J Phys Chem Desember 82(12):2235
Kebede Z, Lindquist SE (1999) Sol Energy Mater Sol Cells 57:259
Stern JH, Passchier AA (1962) J Phys Chem 66:752
Turner DH, Flynn GW, Sutin N, Beitz JV (1972) J Am Chem Soc 94(5):1554
Cherenkova UA, Kotova DL, Kricanova TA, Selemenev BF (2008) Sorpt Chromatogr process 8(2):314
Shart SB, Gellene GI (1997) J Phys Chem A 101:2192
Gottardi W (1999) Arch Pharm Pharm Med Chem 332:151
Gottardi W (1991) in Disinfection, Sterilization and Preservation (Ed.:S.S.Block), Lea & Febiger, Philadelphia, chapter 8
Eaman AS, AL-Rubaee (2014) Int J Sci Nat 5(1):22
Rosu F, Gabelica V, Pauw ED, Antoine R, Broyer M, Dugourd P (2012) J Phys Chem A 116:5383
Wani A, Mushtaq S, Ahsan H, Ahmad R (2012) Asian J Biomed Pharm Sci 2(13):23
Perveen F, Qureshi R, Ansari FL, Kalsoom S, Ahmed S (2011) J Mol Struct 1004:67
Sirajuddin M, Saqib Ali, Badshah A (2013) J Photochem Photobiol B Biol 124:1
Yuldasheva G, Argirova R, Ilin A (2015) AIDS Clin Res 6(6):2
Yuldasheva G, Zhidomirov G, Ilin A (2011) Nat Sci 3(7):573
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yuldasheva, G.A., Zhidomirov, G.M., Leszczynski, J., Ilin, A.I. (2016). Iodine Containing Drugs: Complexes of Molecular Iodine and Tri-iodide with Bioorganic Ligands and Lithium Halogenides in Aqueous Solutions. In: Leszczynski, J., Shukla, M. (eds) Practical Aspects of Computational Chemistry IV. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7699-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7699-4_10
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7697-0
Online ISBN: 978-1-4899-7699-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)